|
|||||
       |
(Photos8.com) Researchers from universities of Michigan and Wisconsin, with colleagues from Oxford and Imperial College in the U.K., have developed a process for creating from stem cells, heart muscle cells that mimic the heart’s pumping action. The findings, which include a technology to measure electrical activity in these created cells, are published as . . . → Read More: Method Devised for Stem Cell Cardiac Muscle Patches  One comment - (Comments are closed)  New products  biomedical, engineering, heart disease, life sciences, medical device, stem cells, university Mycobacterium (CDC.gov) Environmental health researchers at University of Cincinnati in Ohio have identified two specific bacteria associated with contamination in water-damaged buildings, a potential cause of health problems. The team that includes a colleague from the U.S. Environmental Protection Agency, presented its findings yesterday at an American Society for Microbiology meeting in San . . . → Read More: Bacteria Linked to Indoor Building Water Damage Identified Michele Ostraat, Nanomaterial Registry principal investigator (RTI International) RTI International in North Carolina has started the Nanomaterial Registry, a Web-based database and resource of biological and environmental information on materials developed through nanotechnology. The registry, available free to the public, is funded by three agencies of National Institutes of Health: National Institute of . . . → Read More: Nanomaterials Registry Begun for Health, Environment Queries One comment - (Comments are closed) Regulations biomedical, cancer, chemistry, engineering, life sciences, manufacturing, materials science, nanotechnology, NIH, physical sciences (A. Kotok) Seaside Therapeutics in Cambridge, Massachusetts and the Swiss pharmaceutical company Roche will collaborate to develop treatments for autism spectrum disorders and fragile X syndrome. Financial terms of the agreement were not disclosed. Autism spectrum disorders and fragile X syndrome are neurodevelopmental disorders for which there are no effective treatments yet that . . . → Read More: Roche, Seaside Therapeutics to Partner on Autism, Fragile X Comments are closed Joint ventures/collaborations biomedical, biotechnology, licensing, life sciences, pharmaceuticals (U.S. Army Corps of Engineers) Emergent BioSolutions Inc. in Rockville, Maryland was awarded a contract from Biomedical Advanced Research and Development Authority (BARDA) to establish a development center for medical countermeasures against public health emergencies. BARDA is a division of the U.S. Department of Health and Human Services (HHS). The eight-year contract is . . . → Read More: Vaccine Developer Awarded Countermeasures Center Contract One comment - (Comments are closed) Finance biomedical, contract, engineering, life sciences, manufacturing, pharmaceuticals Girls at a malaria prevention event in Ghana (USAID.gov) A report by BIO Ventures for Global Health, a not-for-profit organization related to the Biotechnology Industry Organization (BIO), says only about five percent of the world’s biotechnology companies are developing new drugs, vaccines, or diagnostics against neglected diseases. The report, Biotechnology: Bringing Innovation to . . . → Read More: Report: Few Biotechs Working on Neglected Diseases One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, life sciences, medical device, pharmaceuticals Tiramisu iPhone start page (Tiramisu Transit LLC) A company formed by developers of a smartphone program that tracks real-time bus or light rail locations and seating has received a Small Business Innovation Research (SBIR) grant to commercialize the app. Tiramisu Transit LLC, a spin-off company formed by researchers at Carnegie Mellon University in . . . → Read More: Carnegie Mellon Spin-Off Gets Transportation SBIR Funding One comment - (Comments are closed) Finance computer science, engineering, entrepreneurs, grant, physical sciences, software, university Peter Schultz (Scripps Research Institute) Ambrx Inc., a biopharmaceutical company in La Jolla, California, will collaborate with the global pharmaceutical maker Merck, to design and develop biologic drug conjugates, antibodies connected to drug payloads that bind with disease cell targets. The deal has a value of up to $303 million for Ambrx. The . . . → Read More: Merck, Ambrx to Partner on Biologics Candidate Development One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, chemistry, licensing, life sciences, pharmaceuticals The venture capital company Index Ventures, based in London, unveiled a €350 million ($442 million) fund to invest largely in start-up technology companies. The company expects to focus its new investments on European enterprises, but include start-ups in the U.S. and Israel as well. Index Ventures plans to concentrate on seed and early-stage investments in . . . → Read More: Venture Fund to Invest $442M in Europe, U.S. Start-Ups Comments are closed Finance computer science, entrepreneurs, equity, Europe, investment, Israel, life sciences, software, venture capital (FDA.gov) A study by researchers at Michigan State and Kansas State universities has found warning labels on prescription drugs have limited effectiveness due in large part to their inability to get the attention of users. The results of the study appear this week in the online journal PLoS One. The team led by . . . → Read More: Prescription Warning Label Effectiveness Found Limited |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.